Hasil Pencarian (1)
small molecule | CAS: 1306760-87-1
Ozanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease. It was developed by Celgene (now acquired by Bristol-Myers Squibb) [L11025] and was approved by the FDA …
Kategori:
Antineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCytochrome P-450 CYP2C8 Substrates
+13
Target Protein:
Sphingosine 1-phosphate receptor 1Sphingosine 1-phosphate receptor 5
Waktu ParuhThe half-life of oz…
Vol. DistribusiThe average volume …
KlirensThe mean apparent o…
Genetik
-